Skip to main content

Sibold William John's Form 4 filing

Madrigal Pharmaceuticals, Inc. (MDGL) · filed Sep 11, 2026

Accession no.
0001628280-26-061581
Filed
Sep 11, 2026, 4:57 PM ET
Trade date
Sep 9-11, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 24 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.24M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sibold William JohnCIK 0001518611Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 9, 2026Common StockSSaleDisposed−131$527.88−$69,152.06209,198Direct
Sep 9, 2026Common StockSSaleDisposed−347$529.27−$183,655.68208,851Direct
Sep 9, 2026Common StockSSaleDisposed−522$530.23−$276,780.63208,329Direct
Sep 9, 2026Common StockSSaleDisposed−368$531.99−$195,772.21207,961Direct
Sep 9, 2026Common StockSSaleDisposed−512$533.09−$272,943.72207,449Direct
Sep 9, 2026Common StockSSaleDisposed−396$534.20−$211,541.77207,053Direct
Sep 9, 2026Common StockSSaleDisposed−644$535.27−$344,715.1206,409Direct
Sep 9, 2026Common StockSSaleDisposed−1,040$536.11−$557,556.79205,369Direct
Sep 9, 2026Common StockSSaleDisposed−640$537.17−$343,791.23204,729Direct
Sep 9, 2026Common StockSSaleDisposed−520$538.30−$279,914.49204,209Direct
Sep 9, 2026Common StockSSaleDisposed−215$539.03−$115,891.04203,994Direct
Sep 9, 2026Common StockSSaleDisposed−505$540.19−$272,796.4203,489Direct
Sep 9, 2026Common StockSSaleDisposed−362$541.65−$196,078.68203,127Direct
Sep 9, 2026Common StockSSaleDisposed−160$542.55−$86,807.6202,967Direct
Sep 11, 2026Common StockSSaleDisposed−60$533.09−$31,985.48202,907Direct
Sep 11, 2026Common StockSSaleDisposed−106$534.06−$56,610.68202,801Direct
Sep 11, 2026Common StockSSaleDisposed−218$535.94−$116,835.68202,583Direct
Sep 11, 2026Common StockSSaleDisposed−160$537.62−$86,018.8202,423Direct
Sep 11, 2026Common StockSSaleDisposed−687$540.59−$371,382.38201,736Direct
Sep 11, 2026Common StockSSaleDisposed−368$541.64−$199,324.37201,368Direct
Sep 11, 2026Common StockSSaleDisposed−1,202$542.60−$652,209.05200,166Direct
Sep 11, 2026Common StockSSaleDisposed−1,539$544.02−$837,252.94198,627Direct
Sep 11, 2026Common StockSSaleDisposed−761$544.83−$414,616.16197,866Direct
Sep 11, 2026Common StockSSaleDisposed−120$546.38−$65,565.2197,746Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)